CD4 and neoplasm: Methionine supplementation allows its preferential uptake by CD4+ T cells rather than by tumor cells, in turn promoting AMPK activation of CD4+ T cells and restricting PD-1 expression to strengthen anti-tumor immunity and restrict tumor growth in B16 melanoma [90].